• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antithrombotic therapy in atrial fibrillation.

作者信息

Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A

出版信息

Chest. 1995 Oct;108(4 Suppl):352S-359S. doi: 10.1378/chest.108.4_supplement.352s.

DOI:10.1378/chest.108.4_supplement.352s
PMID:7555188
Abstract
摘要

相似文献

1
Antithrombotic therapy in atrial fibrillation.心房颤动的抗栓治疗
Chest. 1995 Oct;108(4 Suppl):352S-359S. doi: 10.1378/chest.108.4_supplement.352s.
2
[Antithrombotic treatment of atrial fibrillation in hospital].
Tidsskr Nor Laegeforen. 2001 Oct 10;121(24):2800-4.
3
Antithrombotic treatment in chronic non-rheumatic atrial fibrillation.慢性非风湿性心房颤动的抗栓治疗
Neth J Med. 1997 Aug;51(2):51-6. doi: 10.1016/s0300-2977(97)00039-9.
4
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.非维生素K拮抗剂口服抗凝药时代之前心房颤动患者的抗栓治疗：心房颤动患者长期口服抗栓治疗全球注册研究（GLORIA-AF）第一阶段队列研究
Europace. 2016 Sep;18(9):1308-18. doi: 10.1093/europace/euw073. Epub 2016 Jun 21.
5
Antithrombotic therapy in atrial fibrillation.心房颤动的抗栓治疗
Clin Geriatr Med. 2006 Feb;22(1):155-66, x. doi: 10.1016/j.cger.2005.09.011.
6
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.房颤合并冠状动脉疾病患者的三联与双联抗栓治疗
Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.
7
[Antithrombotic therapy in atrial fibrillation].[心房颤动的抗栓治疗]
Acta Med Port. 1999 Jul-Nov;12(7-11):245-54.
8
Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.基于人群的心房颤动抗栓治疗管理评估
Can J Cardiol. 2005 Mar;21(3):257-66.
9
Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.欧洲心脏病学会指南指导下的抗栓治疗改善了高危房颤患者的预后：来自 EORP-AF 一般试点登记处的报告。
Europace. 2015 Dec;17(12):1777-86. doi: 10.1093/europace/euv269. Epub 2015 Aug 30.
10
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.非瓣膜性心房颤动卒中预防的抗血栓治疗。
Lancet Neurol. 2012 Dec;11(12):1066-81. doi: 10.1016/S1474-4422(12)70258-2.

引用本文的文献

1
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.体外电复律和药物复律治疗心房颤动、心房扑动或房性心动过速的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD013255. doi: 10.1002/14651858.CD013255.pub2.
2
Effectiveness of Anticoagulants in Reducing Stroke Risk Among Patients With Atrial Fibrillation.抗凝剂在降低心房颤动患者中风风险方面的有效性。
Cureus. 2024 Apr 29;16(4):e59298. doi: 10.7759/cureus.59298. eCollection 2024 Apr.
3
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation.
心房颤动患者缺血性卒中、颅内出血及死亡率的当代发病趋势。
Eur Heart J Qual Care Clin Outcomes. 2025 May 1;11(3):228-238. doi: 10.1093/ehjqcco/qcae022.
4
Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients.心力衰竭患者中房颤的药物转律与节律控制。
Medicina (Kaunas). 2022 May 30;58(6):743. doi: 10.3390/medicina58060743.
5
Warfarin Pharmacogenetics: New Life for an Old Drug.华法林药物遗传学：一种老药的新生命
Acta Cardiol Sin. 2013 May;29(3):235-42.
6
Left atrial thrombus formation and resolution during dabigatran therapy: A Japanese Heart Rhythm Society report.达比加群治疗期间左心房血栓形成与溶解：日本心律学会报告
J Arrhythm. 2015 Aug;31(4):226-31. doi: 10.1016/j.joa.2014.12.010. Epub 2015 Mar 4.
7
Pharmacogenetics of warfarin: challenges and opportunities.华法林的药物遗传学：挑战与机遇。
J Hum Genet. 2013 Jun;58(6):334-8. doi: 10.1038/jhg.2013.40. Epub 2013 May 9.
8
Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians.阿昔单抗的治疗剂量：提出一种特定人群的药物遗传学剂量算法及其在印度北部人群中的验证。
PLoS One. 2012;7(5):e37844. doi: 10.1371/journal.pone.0037844. Epub 2012 May 22.
9
Pharmacogenetics of oral anticoagulants: a basis for dose individualization.口服抗凝剂的药物遗传学：剂量个体化的基础。
Clin Pharmacokinet. 2008;47(9):565-94. doi: 10.2165/00003088-200847090-00002.
10
Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?持续性心房颤动复律后长期窦性心律维持：治疗成功是否可预测？
Heart Vessels. 2006 Nov;21(6):375-81. doi: 10.1007/s00380-006-0915-3. Epub 2006 Nov 27.